Literature DB >> 10967218

Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals.

S van Drunen Littel-van den Hurk1, V Gerdts, B I Loehr, R Pontarollo, R Rankin, R Uwiera, L A Babiuk.   

Abstract

DNA-based vaccination constitutes one of the most recent approaches to vaccine development. This technology is in principle one of the most simple and yet versatile methods of inducing both humoral and cellular immune responses, as well as protection against a variety of infectious agents. However, although immune responses have been induced in a number of larger species, most information on the efficacy of DNA immunization has been generated in mice. In this review the information available to date about the use of DNA vaccines in farmed animals, including cattle, pigs and poultry, is presented. The areas that need specific attention in the future to bring this technology to the market are discussed, including the issues concerning delivery, safety, compatibility of plasmids in multivalent vaccines and the potential of using immune stimulants as part of a DNA vaccine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10967218     DOI: 10.1016/s0169-409x(00)00074-0

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  8 in total

Review 1.  Expression library immunization: a road map for discovery of vaccines against infectious diseases.

Authors:  Adel M Talaat; Katherine Stemke-Hale
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

2.  Infertility in mice induced by the rhesus monkey chorionic gonadotropin beta-subunit glycoprotein (rmCGbeta) using DNA immunization.

Authors:  Yun Chen; Zhe Liu; Ying Yang; You-Zhen Chen; Jing-Pian Peng
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

3.  TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.

Authors:  Shawn Babiuk; Neeloffer Mookherjee; Reno Pontarollo; Phillip Griebel; Sylvia van Drunen Littel-van den Hurk; Rolf Hecker; Lorne Babiuk
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

4.  A DNA fusion vaccine induces bactericidal antibodies to a peptide epitope from the PorA porin of Neisseria meningitidis.

Authors:  Delin Zhu; Jeannette N Williams; Jason Rice; Freda K Stevenson; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

5.  Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses In The Lung.

Authors:  Yumeng Li; Chuan Wang; Zhenjie Sun; Jian Xiao; Xiaoliang Yan; Yuqing Chen; Jian Yu; Yimou Wu
Journal:  Int J Nanomedicine       Date:  2019-10-08

Review 6.  Chlamydia trachomatis vaccine research through the years.

Authors:  Katelijn Schautteet; Evelien De Clercq; Daisy Vanrompay
Journal:  Infect Dis Obstet Gynecol       Date:  2011-06-26

7.  In vitro analysis of expression vectors for DNA vaccination of horses: the effect of a Kozak sequence.

Authors:  Gudbjörg Olafsdóttir; Vilhjálmur Svansson; Sigurdur Ingvarsson; Eliane Marti; Sigurbjörg Torsteinsdóttir
Journal:  Acta Vet Scand       Date:  2008-11-04       Impact factor: 1.695

8.  Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.

Authors:  Pengfei Jiang; Wangqi Du; Yirong Xiong; Yan Lv; Juan Feng; Shanli Zhu; Xiangyang Xue; Shao Chen; Lifang Zhang
Journal:  Oncotarget       Date:  2015-12-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.